JG
TEVA icon

Jain Global’s Teva Pharmaceuticals TEVA Stock Holding History

Jain Global’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-201,313
Closed -$6.28M – 1646
2025
Q4 		$6.28M Sell
201,313
-37,981
-16% -$936K 0.03% 394
2025
Q3 		$4.83M Buy
+239,294
New +$4.2M 0.02% 367
2025
Q2 		– Sell
-273,089
Closed -$4.2M – 1607
2025
Q1 		$4.2M Buy
273,089
+179,186
+191% +$3.2M 0.05% 254
2024
Q4 		$2.07M Buy
+93,903
New +$1.71M 0.06% 233

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jain Global's TEVA Position: Q1 2026 in Review

Jain Global sold out of Teva Pharmaceuticals (TEVA) in Q1 2026, closing a stake of 201,313 shares — an estimated $6.28M sold.

Jain Global first reported a position in TEVA in Q4 2024 and held it in 4 quarters. The position peaked at $6.28M in Q4 2025. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Jain Global reported no remaining Teva Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Jain Global sold 201,313 Teva Pharmaceuticals shares in Q1 2026, an estimated $6.28M.
  • Jain Global first reported a position in Teva Pharmaceuticals in Q4 2024 and held it in 4 quarters.
  • Jain Global's Teva Pharmaceuticals position peaked at $6.28M in Q4 2025.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.